Dundee Corp T.DC.A

Europeans negative on Biogen Alzheimers drug

[jrj90620]

Hopefully,TauRx drug is liked better.
https://www.reuters.com/business/healthcare-pharmaceuticals/european-alzheimers-experts-unconvinced-by-new-eisai-biogen-drug-2023-06-13/?utm_source=Sailthru&utm_medium=Newsletter&utm_campaign=Health-Rounds&utm_term=061323

[TheCount11]

Approval would be a huge upside surprise for Dundee.  It seems to me investors are taking a wait and see approach to TauRx.  

[Macpoor]

Unlike Biogen , TauRx's patients no need to go to the hospitals . No MRI  or scan envolve . Pure and simple , take the pill at home or carry it in your fanny bag and we're good to go! 

[TheCount11]

Given all the benefits I have yet to see any indication that TauRx has applied to FDA.  The trial is over.  Apply already.

[pierrelebel]

"The trial is over.  Apply already." Not quite! On 6 October 2022, the company TauRx Therapeutics Ltd announced results from its LUCIDITY Phase III trial for the treatment of Alzheimer’s disease (AD). The LUCIDITY trial is a randomised, double-blind and placebo-controlled study evaluating the safety and efficacy of hydromethylthionine mesylate (HMTM) in people with AD ranging

[TheCount11]

Right.  Aren't OLEs normally to show longer time horizon for safety?  Throught TauRx had a good safety profile so why not apply now?